AC-1101 Topical Gel

· TWi Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-1101 Topical Gel, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare [Phase 1]

See pricing